Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension of rotigotine patch in idiopathic Parkinson's disease
2004-002641-12Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rotigotine in Parkinson's disease (PD), sponsored by Schwarz Pharma. Primary endpoint: Frequency and severity of adverse events. Started Dec 2004; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-002641-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002641-12.